Press Room

Visit our press room for current and past releases about our company.
December 10, 2018

Altasciences Contributes to Positive Top-Line Phase I Results for Chronic Cough Drug Candidate

Altasciences recently completed an important First-in-Human (FIH), Phase I, integrated adaptive clinical trial, including single and multiple ascending doses (SAD and MAD), Project Management, Bioanalysis, and Medical Writing, for sponsor Bellus Health.

November 08, 2018

Altasciences Completes Bioanalytical Laboratory Expansion

Altasciences is excited to announce the completion of their laboratory expansion.

October 01, 2018

Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff

Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. 

September 25, 2018

Altasciences to present Continuing Education Course at the New York State Bar Association

Altasciences is pleased to announce that Dr. Graham K. Wood, Chief R&D Officer at Altasciences, is presenting at a Continuing Legal Education program entitled Practical Implications of Decriminalized Marijuana for the Legal Practitioner on Wednesday, October 3.

September 06, 2018

Dr. William J. Foster Joins Altasciences as Principal Investigator

Altasciences is pleased to welcome Dr. William J. Foster, MD, PhD, FRCSC, to the Altasciences family as Principal Investigator and Consultant on clinical trials.